Article Details
Retrieved on: 2024-01-26 18:18:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Danaher's (DHR) Q4 earnings are likely to have been hurt by weakness in the Biotechnology and Diagnostics units owing to lower sales of ...
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here